ABRO 1, RESITON GINGIVA, PRIME and THERAPON TRANSPA— 510(k) K200676

Substantially Equivalent

Zirkonzahn Srl

FDA 510(k) clearance K200676 for ABRO 1, RESITON GINGIVA, PRIME and THERAPON TRANSPA, Substantially Equivalent on 2020-07-08. Applicant: Zirkonzahn Srl.

Clearance details

Applicant: Zirkonzahn Srl
Product code: Code EBG
Advisory panel: Dental
Date received: 2020-03-16
Decision date: 2020-07-08
Decision: Substantially Equivalent
Clearance type: Traditional
Location: Gais, IT

Download summary PDF View on FDA.gov ↗

Data sourced from openFDA. This site is unofficial and independent of the FDA.